Daily pill help treat blood
Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Sports ~ Technology ~ Health ~ Features
Breast Cancer ~ Swine Flu ~ Lung Cancer ~ Heart attack ~ Pregnancy ~ All Health Topics
Home / Health News / 2009 / July 2009 / July 26, 2009
Daily pill may help treat blood cancer patients
RSS / Print / Comments

Health News

Waist size, not BMI can foretell cardiovascular risk in children
A new study by researchers at the University of Georgia, the Menzies Research Institute in Hobart, Australia and the Murdoch Childrens Research Institute in Melbourne, Australia has found that waist circumference is a better indicator of a childs risk for cardiovascular disease and diabetes later in life, as compared to BMI. ANI

Internal body temperature regulates body clock
Fluctuations in internal body temperature regulate the bodys circadian rhythm, the 24-hour cycle that controls metabolism, sleep and other bodily functions, revealed UT Southwestern Medical Center researchers. ANI

Egyptian mummies discovery indicates 'cancer is man-made'
A study of ancient remains has found that cancer is a man-made disease fuelled by pollution and changes to diet and lifestyle. ANI

Daily pill may help treat blood cancer patients

Blood cancer, which has traditionally given sufferers a survival time of just a few years, may soon be curable with the aid of a daily pill.

Melbourne, July 26 : Blood cancer, which has traditionally given sufferers a survival time of just a few years, may soon be curable with the aid of a daily pill.

Cancer specialists meeting in Melbourne this weekend are likely to discuss how in future doctors should treat myeloma, an incurable blood cancer which effects thousands of people.

This form of cancer develops in the bone marrow, inhibits the production of normal blood cells, and causes symptoms such as anaemia, fatigue and infections.

"We are seeing a major advance in the treatment of multiple myeloma," news.com.au quoted Royal Melbourne Hospital oncologist Professor Jeffrey Szer as saying in a statement.

"In the past five years for instance, myeloma patient survival, which has traditionally been three to four years, has been significantly extended with the availability of innovative new medicines," Szer added.

Thos present at the meeting are likely to hear that a medicine called Revlimid may possibly be used as an oral treatment for the condition.

"We are seeing a significant improvement in quality of life and cancer survival rates," Szer said.

"There are a number of new treatment strategies that clinicians are adopting to enable them to achieve these outcomes.

"Revlimid is an example of an innovative new medicine that has a unique mechanism of action to kill cancer cells and prolong the patient's life. Compelling Revlimid clinical trail data is being discussed at (the) medical symposium this weekend with local and international experts, coinciding with the Leukaemia Foundation's public lecture," Szer added.


Link to this page

Suggested pages for your additional reading
AndhraNews.net on Facebook

© 2000-2017 AndhraNews.net. All Rights Reserved and are of their respective owners.
Disclaimer, Terms of Service & Privacy Policy | Contact Us